<ARTICLE> 5 <LEGEND> This schedule contains summary information extracted from Intel Corporation's CONSOLIDATED CONDENSED STATEMENTS OF INCOME AND CONSOLIDATED BALANCE SHEETS and is qualified in its entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-28-1996 <PERIOD-END> MAR-30-1996 <CASH> 1955 <SECURITIES> 1470 <RECEIVABLES> 3101<F3> <ALLOWANCES> 0 <INVENTORY> 1544 <CURRENT-ASSETS> 8632 <PP&E> 12535 <DEPRECIATION> 4671 <TOTAL-ASSETS> 18219 <CURRENT-LIABILITIES> 3510 <BONDS> 398 <PREFERRED-MANDATORY> 734<F1> <PREFERRED> 0 <COMMON> 2646 <OTHER-SE> 0 <TOTAL-LIABILITY-AND-EQUITY> 18219 <SALES> 4644 <TOTAL-REVENUES> 4644 <CGS> 2421 <TOTAL-COSTS> 2421 <OTHER-EXPENSES> 401<F2> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 5 <INCOME-PRETAX> 1376 <INCOME-TAX> 482 <INCOME-CONTINUING> 894 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 894 <EPS-PRIMARY> 1.02 <EPS-DILUTED> 0 <FN> <F1>Item consists of put warrants. <F2>Item consists of research and development. <F3>Item shown net of allowance, consistent with the balance sheet presentation. </FN>